Respirology

Previous issue Volume 22 Issue 1
January 2017
Next issue
Index Submit
an article
About
Respirology
Read this
issue's articles
EDITORIALS
7Respirology and the Asia-Pacific Century
Philip Bardin & Paul Reynolds
10.1111/resp.12953
9Adult asthma quick reference guides: Trans-Tasman differences in opinion
Richard Beasley, Darmiga Thayabaran & Robert J Hancox
10.1111/resp.12935
12Clinical value of pulmonary hyperinflation as a treatment outcome in cystic fibrosis
Daniel Stevens
10.1111/resp.12906
SERIES EDITORIALS – PROLOGUE/EPILOGUE
14A new era in idiopathic interstitial pneumonias: Epilogue to a review series
Tamera J Corte, Harold Collard & Athol U Wells
10.1111/resp.12921
17Update in respiratory sleep disorders: Prologue to a modern review series
Peter R Eastwood, Mary J Morrell & Atul Malhotra
10.1111/resp.12959
19Severe asthma: Can we fix it? Prologue to seeking innovative solutions for severe asthma
Vanessa M McDonald, Steven Maltby & Peter G Gibson
10.1111/resp.12956
INVITED REVIEW SERIES
Unravelling the Many Faces of COPD to Optimize Its Care and Outcomes
21Animal models of COPD: What do they tell us?
Bernadette Jones, Chantal Donovan, Gang Liu, Henry M Gomez, Vrushali Chimankar, Celeste L Harrison, Cornelis H Wiegman, Ian M Adcock, Darryl A Knight, Jeremy A Hirota & Philip M Hansbro
10.1111/resp.12908
Respiratory Sleep Disorders
33Obstructive sleep apnoea pathogenesis from mild to severe: Is it all the same?
Bradley A Edwards, Danny J Eckert & Amy S Jordan
10.1111/resp.12913
43Pathogenesis of central and complex sleep apnoea
Jeremy E Orr, Atul Malhotra & Scott A Sands
10.1111/resp.12927
Seeking Innovative Solutions for Severe Asthma
53Severe asthma: Current management, targeted therapies and future directions – A roundtable report
Vanessa M McDonald, Steven Maltby, Helen K Reddel, Gregory G King, Peter A B Wark, Lorraine Smith, John W Upham, Alan L James, Guy B Marks & Peter G Gibson
10.1111/resp.12957
SYSTEMATIC REVIEW
61Do inhaled corticosteroids protect against lung cancer in patients with COPD? A systematic review
Adam J N Raymakers, Natalie McCormick, Carlo A Marra, J Mark Fitzgerald, Don Sin & Larry D Lynd
10.1111/resp.12919
ORIGINAL ARTICLES
Asthma and Allergy
71Association between levels of fractional exhaled nitric oxide and asthma exacerbations in Thai children
Nualanong Visitsunthorn, Nawinda Mahawichit & Kittipong Maneechotesuwan
10.1111/resp.12857

The fractional exhaled nitric oxide (FeNO) level at a visit before an asthma exacerbation (AE) was significantly higher in asthmatic patients who experienced an AE within the next 12 months. The optimal cut-off point of FeNO level for the prediction of an AE is 31 ppb.

78Comprehensive attenuation of IL-25-induced airway hyperresponsiveness, inflammation and remodelling by the PI3K inhibitor LY294002
Ping Huang, Yan Li, Ze Lv, Jingjing Wang, Qian Zhang, Xiujuan Yao, Chris J Corrigan, Kewu Huang, Wei Wang & Sun Ying
10.1111/resp.12880

The phosphoinositide 3-kinase (PI3K) pan-inhibitor LY294002 effectively attenuated IL-25-induced airway inflammation, hyperresponsiveness and remodelling in a murine asthma model in an in vivo condition.

86Clinically remitted childhood asthma is associated with airflow obstruction in middle-aged adults
Keitaro Omori, Hiroshi Iwamoto, Takashi Yamane, Taku Nakashima, Yoshinori Haruta, Noboru Hattori, Akihito Yokoyama & Nobuoki Kohno
10.1111/resp.12860

We performed a large cross-sectional analysis to evaluate the association of remitted childhood asthma with lung function in middle-aged adults. We found that not only adulthood asthma, but also remitted childhood asthma was associated with airflow obstruction.

93Inhibition of IL-13-induced periostin in airway epithelium attenuates cellular protein expression of MUC5AC
Isao Suzaki, Shuichi Kawano, Kosaku Komiya, Tsuyoshi Tanabe, Tomohiro Akaba, Kazuhito Asano, Harumi Suzaki, Kenji Izuhara & Bruce K Rubin
10.1111/resp.12873

Airway epithelial cells, in particular goblet cells, appear to be an important source of periostin in the serum and sputum of asthmatic patients. IL-13 induced periostin production in NHBE cells and this was mediated by Janus kinase (JAK)/signal transducer and activator of transcription factor 6 (STAT6) and MEK/extracellular regulated protein kinase (ERK) pathways. Inhibiting periostin attenuated IL-13-driven MUC5AC mucin secretion.

Bronchiectasis
101Bronchiectasis in yellow nail syndrome
Georgia Woodfield, Mitzi Nisbet, Joe Jacob, Wing Mok, Michael R Loebinger, David M Hansell, Athol U Wells & Robert Wilson
10.1111/resp.12866

Bronchiectasis in yellow nail syndrome (YNS) has distinct features which influence clinical presentation and management. Bronchiectasis in YNS is milder than in idiopathic bronchiectasis, with less upper and middle lobe disease, but increased mucus plugging. A better understanding of aetiology may influence future research and management decisions.

108Bronchoarterial ratio in never-smokers adults: Implications for bronchial dilation definition
Alejandro A Diaz, Thomas P Young, Diego J Maselli, Carlos H Martinez, Erick S Maclean, Andrew Yen, Chandra Dass, Scott A Simpson, David A Lynch, Gregory L Kinney, John E Hokanson, George R Washko & Raul San José Estépar
10.1111/resp.12875

In 106 never-smokers adults, the mean ratio of the diameters of the bronchial lumen and adjacent pulmonary artery, a defining radiological feature of bronchiectasis, was 0.79, varied by airway generation and in 8.5% of them was >1. This metric was directly related with expiratory airflow regardless of body size.

COPD
114Role of BMI, airflow obstruction, St George's Respiratory Questionnaire and age index in prognostication of Asian COPD
Hiang Ping Chan, Amartya Mukhopadhyay, Pauline Lee Poh Chong, Sally Chin, Xue Yun Wong, Venetia Ong, Yiong Huak Chan, Tow Keang Lim & Jason Phua
10.1111/resp.12877

The BMI, airflow obstruction, St George's Respiratory Questionnaire and age (BOSA) index is a new tool, built and prospectively validated in this study for prognosticating patients with COPD. It predicts mortality moderately well and is at least equivalent to Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2011 in Asian patients. It has the potential to be used widely as complex testing or equipment is not required.

120Exercise hypoxaemia as a predictor of pulmonary hypertension in COPD patients without severe resting hypoxaemia
Yoshio Nakahara, Hiroyuki Taniguchi, Tomoki Kimura, Yasuhiro Kondoh, Shinichi Arizono, Koichi Nishimura, Koji Sakamoto, Satoru Ito, Masahiko Ando & Yoshinori Hasegawa
10.1111/resp.12863

In patients with COPD without resting hypoxaemia, mean pulmonary artery pressure (mPAP) significantly correlated with oxygen saturation of peripheral artery (SpO2 ) at the end of the 6-min walk test (6MWT). In multivariate analysis, only SpO2 at the end of the 6MWT and 6-min walk distance (6MWD) remained as independent predictors of mPAP. Thus, exercise capacity and exercise hypoxaemia predict pulmonary hypertension (PH) in COPD patients without resting hypoxaemia.

126Expression of RANKL by peripheral neutrophils and its association with bone mineral density in COPD
XiaoLing Hu, Yongchang Sun, Weihan Xu, Tao Lin & Hui Zeng
10.1111/resp.12878

Peripheral blood neutrophils from male patients with COPD had enhanced expression of the osteoclast activation factor RANKL (receptor activator of NF-kB ligand), which correlated with bone mineral density and lung function of the patients.

133Transforming growth factor (TGF) β1 and Smad signalling pathways: A likely key to EMT-associated COPD pathogenesis
Malik Q Mahmood, David Reid, Chris Ward, Hans K Muller, Darryl A Knight, Sukhwinder S Sohal & Eugene H Walters
10.1111/resp.12882

COPD is fundamentally due to small airway fibrosis mainly in smokers. Pathologically, it is associated with active epithelial mesenchymal transition (EMT). Relatively, little has been studied regarding the transforming growth factor (TGF)-β1-pSmad pathway in smokers and COPD. This study facilitates the understanding of EMT-associated pathogenesis of COPD in terms of this pathway.

Cystic fibrosis
141Relationship between pulmonary hyperinflation and dyspnoea severity during acute exacerbations of cystic fibrosis
Trevor T Nicholson, Peter J Barry, Deirdre F Waterhouse, Geraldine M Nolan, Edward F McKone & Charles G Gallagher
10.1111/resp.12885

This study explores the relationship between dyspnoea and pulmonary function during acute exacerbations of cystic fibrosis (CF). Indicators of pulmonary hyperinflation, rather than forced expiratory volume in 1s (FEV1), are associated with the severity of dyspnoea during treatment. As total lung capacity (TLC) does not change with treatment, inspiratory capacity (IC) measurement may provide a useful means of assessing treatment response.

Environmental & Occupational Lung Disease
149
Ecological study on solid fuel use and pneumonia in young children: A worldwide association
Roberto A Accinelli, Juan A Leon-Abarca & David Gozal
10.1111/resp.12865

Solid fuels and associated biomass pollution have been implicated in an expanded array of adverse health effects. We performed a worldwide ecological assessment and identified that in addition to poverty and other economic indicators, solid fuels independently contribute to the prevalence of acute pneumonia in young children.

Pulmonary Vascular Disease
157Bromodomain and extra-terminal protein mimic JQ1 decreases inflammation in human vascular endothelial cells: Implications for pulmonary arterial hypertension
Sharon Mumby, Natalia Gambaryan, Chao Meng, Frederic Perros, Marc Humbert, S John Wort & Ian M Adcock
10.1111/resp.12872

Endothelial cell inflammation and proliferation are important in the pathogenesis of pulmonary arterial hypertension (PAH). Bromodomain and extra-terminal (BET) mimics reduced inflammation and cell proliferation in primary human pulmonary vascular endothelial cells. The enhanced histone acetyltransferase (HAT) activity in PAH suggests that BET mimics may be effective in PAH although experiments in disease cells/tissues are required.

165Gas exchange responses during 6-min walk test in patients with pulmonary arterial hypertension
Norman R Morris, Helen Seale, Julie Harris, Kathleen Hall, Aaron C W Lin & Fiona Kermeen
10.1111/resp.12868

Pulmonary arterial hypertension (PAH) patients have reduced exercise tolerance and characteristic gas exchange responses. Inclusion of gas exchange measurements during the 6-min walk test showed that individuals with more severe disease and more advance pharmacotherapy had poorer gas exchange during exercise.

172Prognostic value of right ventricular ejection/filling parameters in IPAH using cardiac magnetic resonance: A prospective pilot study
Wen Li, Tao Yang, Yan Zhang, Qing Gu, Zhi-Hong Liu, Xin-Hai Ni, Qin Luo, Chang-Ming Xiong & Jian-Guo He
10.1111/resp.12861

The prognostic values of cardiovascular magnetic resonance (CMR)-derived right ventricular (RV) ejection/filling parameters in idiopathic pulmonary arterial hypertension (IPAH) patients were examined. RV time to peak ejection rate (TPER) and TPER/time of a cardiac cycle (TCC) were found to reflect RV early systolic function, and thus may be prognostic predictive values for long-term cardiac impairment in IPAH patients.

179Prognostic and pathophysiological marker for patients with chronic thromboembolic pulmonary hypertension: Usefulness of diffusing capacity for carbon monoxide at diagnosis
Rika Suda, Nobuhiro Tanabe, Keiichi Ishida, Fumiaki Kato, Takashi Urushibara, Ayumi Sekine, Rintaro Nishimura, Takayuki Jujo, Toshihiko Sugiura, Ayako Shigeta, Seiichiro Sakao & Koichiro Tatsumi
10.1111/resp.12883

This is the first study identifying decreased diffusing capacity for carbon monoxide (DLCO)/alveolar ventilation (VA) (<80%) as an independent poor prognostic factor in medically treated chronic thromboembolic pulmonary hypertension (CTEPH) patients. This study also demonstrated that DLCO/VA may reflect peripheral microvasculopathy, which is a major cause of poor outcome.

Paediatric Lung Disease
187Risk factors for morbidities and mortality in children following pneumonectomy
Verónica Giubergia, Florencia Alessandrini, Carolina Barrias, Carlos Giuseppucci, Aixa Reusmann, Marcelo Barrenechea & Claudio Castaños
10.1111/resp.12867

Risk factors related to morbidity and mortality after pneumonectomy (PNE) have been described in adults. This study explores the risk factors following PNE in children. Age ≤3 years and the need for ventilation assistance for 4 days or longer was associated with increased risk of morbidity and mortality.

Pleural Disease
192
Malignant pleural fluid from mesothelioma has potent biological activities
Hui Min Cheah, Sally M Lansley, Julius F Varano della Vergiliana, Ai Ling Tan, Rajesh Thomas, Su Lyn Leong, Jenette Creaney & Yun Chor Gary Lee
10.1111/resp.12874

Malignant pleural effusion (MPE) is often viewed as a by-product of cancer with breathlessness as the only significant consequence. Its production and role in cancer biology are unclear. This study provides 'proof-of-concept' evidence revealing potent biological capabilities in cancer progression. Further understanding of MPE may uncover exciting therapeutic possibilities.

SCIENTIFIC LETTER
200Target oxygen saturation range: 92–96% Versus 94–98%
Richard Beasley, Jimmy Chien, James Douglas, Leonie Eastlake, Claude Farah, Gregory King, Rosemary Moore, Janine Pilcher, Michael Richards, Sheree Smith & Haydn Walters
10.1111/resp.12879
CORRESPONDENCE
203Metformin use and asthma: Further investigations
Sreenivas P Veeranki
10.1111/resp.12923
203Metformin use and asthma: Further investigations – Reply
Chun-Yi Li, Steven R Erickson & Chung-Hsuen Wu
10.1111/resp.12922

Index

2024 MayVol. 29 Issue 5
2024 AprVol. 29 Issue 4
2024 MarVol. 29 Issue 3
2023 MarVol. 29 Supplement 1
ANZSRS/TSANZ Annual Scientific Meeting 2024
2024 FebVol. 29 Issue 2
2024 JanVol. 29 Issue 1
2023 DecVol. 28 Issue 12
2023 NovVol. 28 Issue 11
2023 NovVol. 28 Supplement 4
APSR 2023 Congress Abstracts
2023 OctVol. 28 Issue 10
2023 SepVol. 28 Issue 9
2023 AugVol. 28 Issue 8
2023 JulVol. 28 Issue 7
2023 JunVol. 28 Issue 6
2023 MayVol. 28 Issue 5
2023 AprVol. 28 Issue 4
2023 MarVol. 28 Issue 3
2023 MarVol. 28 Supplement 3
Australian Lung Cancer Conference 2023
2023 MarVol. 28 Supplement 2
ANZSRS/TSANZ Annual Scientific Meeting 2023
2023 FebVol. 28 Issue 2
2023 FebVol. 28 Supplement 1
APSR 2022 Congress Abstracts
2023 JanVol. 28 Issue 1
2022 DecVol. 27 Issue 12
2022 NovVol. 27 Issue 11
2022 OctVol. 27 Issue 10
2022 SepWorld Lung Day 2022
2022 SepVol. 27 Issue 9
2022 AugVol. 27 Issue 8
2022 JulVol. 27 Issue 7
2022 JunVol. 27 Issue 6
Special Issue: Occupational Lung Health
2022 MayVol. 27 Issue 5
2022 AprVol. 27 Issue 4
2022 MarVol. 27 Issue 3
2022 MarVol. 27 Issue s1
ANZSRS and TSANZ abstracts
2022 FebVol. 27 Issue 2
2022 JanVol. 27 Issue 1
2021 DecVol. 26 Issue 12
2021 NovVol. 26 Issue 11
2021 NovVol. 26 Supplement 3
APSR Congress Abstracts
2021 OctVol. 26 Issue 10
2021 SepVol. 26 Issue 9
2021 AugVol. 26 Issue 8
2021 JulVol. 26 Issue 7
2021 JunVol. 26 Issue 6
2021 MayVol. 26 Issue 5
2021 AprVol. 26 Issue 4
2021 AprVol. 26 Issue s2
ANZSRS and TSANZ abstracts
2021 MarVol. 26 Issue 3
2021 FebVol. 26 Issue 2
2021 JanVol. 26 Issue s1
Supplement: APSR Assembly Virtual Meetings
2021 JanVol. 26 Issue 1
2020 DecVol. 25 Issue 12
2020 NovVol. 25 Issue 11
2020 NovVol. 25 Issue s2
Essential update in lung cancer medicine
2020 OctVol. 25 Issue 10
2020 SepVol. 25 Issue 9
Special issue: Interventional Pulmonoogy pearls
2020 AugVol. 25 Issue 8
2020 JulVol. 25 Issue 7
2020 JunVol. 25 Issue 6
2020 JunVol. 25 Supplement 1
ANZSRS and TSANZ abstracts
2020 MayVol. 25 Issue 5
2020 AprVol. 25 Issue 4
2020 MarVol. 25 Issue 3
2020 FebVol. 25 Issue 2
2020 JanVol. 25 Issue 1
2019 DecVol. 24 Issue 12
2019 NovVol. 24 Issue 11
2019 NovVol. 24 Supplement 2
APSR Congress Abstracts
2019 OctVol. 24 Issue 10
2019 SepVol. 24 Issue 9
2019 AugVol. 24 Issue 8
2019 JulVol. 24 Issue 7
2019 JunVol. 24 Issue 6
2019 MayVol. 24 Issue 5
2019 AprVol. 24 Issue 4
2019 MarVol. 24 Issue 3
2019 MarVol. 24 Supplement 1
ANZSRS and TSANZ abstracts
2019 FebVol. 24 Issue 2
2019 JanVol. 24 Issue 1
2018 DecVol. 23 Issue 12
2018 NovVol. 23 Supplement 2
APSR Congress Abstracts
2018 NovVol. 23 Issue 11
2018 OctVol. 23 Issue 10
2018 SepVol. 23 Issue 9
2018 AugVol. 23 Issue 8
2018 JulVol. 23 Issue 7
2018 JunVol. 23 Issue 6
2018 MayVol. 23 Issue 5
2018 AprVol. 23 Issue 4
2018 MarVol. 23 Supplement 1
ANZSRS and TSANZ abstracts
2018 MarVol. 23 Issue 3
2018 FebVol. 23 Issue 2
2018 JanVol. 23 Issue 1
2017 NovVol. 22 Supplement 3
APSR Congress Abstracts
2017 NovVol. 22 Issue 8
2017 OctVol. 22 Issue 7
2017 AugVol. 22 Issue 6
2017 JulyVol. 22 Issue 5
2017 MayVol. 22 Issue 4
2017 AprVol. 22 Issue 3
2017 MarVol. 22 Supplement 2
ANZSRS and TSANZ abstracts
2017 MarVol. 22 Supplement 1
Airway Vista abstracts
2017 FebVol. 22 Issue 2
2017 JanVol. 22 Issue 1
2016 NovVol. 21 Supplement 3
APSR Congress Abstracts
2016 NovVol. 21 Issue 8
2016 OctVol. 21 Issue 7
2016 AugVol. 21 Issue 6
2016 JulVol. 21 Issue 5
2016 MayVol. 21 Issue 4
2016 AprVol. 21 Supplement 2
ANZSRS and TSANZ abstracts
2016 AprVol. 21 Issue 3
2016 MarVol. 21 Supplement 1
Airway Vista abstracts
2016 FebVol. 21 Issue 2
2016 JanVol. 21 Issue 1
2015 DecVol. 20 Supplement 3
APSR Congress Abstracts
2015 NovVol. 20 Issue 8
2015 OctVol. 20 Issue 7
2015 AugVol. 20 Issue 6
2015 JulVol. 20 Issue 5
2015 MayVol. 20 Issue 4
2015 AprVol. 20 Issue 3
2015 MarVol. 20 Supplement 2
ANZSRS and TSANZ abstracts
2015 MarVol. 20 Supplement 1
Airway Vista abstracts
2015 FebVol. 20 Issue 2
2015 JanVol. 20 Issue 1
2014 NovVol. 19 Issue 8
2014 NovVol. 19 Supplement 3
APSR Congress Abstracts
2014 OctVol. 19 Issue 7
2014 AugVol. 19 Issue 6
2014 JulVol. 19 Issue 5
2014 MayVol. 19 Issue 4
2014 AprVol. 19 Issue 3
2014 AprVol. 19 Supplement 2
ANZSRS and TSANZ abstracts
2014 MarVol. 19 Supplement 1
Airway Inflammation
2014 FebVol. 19 Issue 2
2014 JanVol. 19 Issue 1
2013 NovVol. 18 Issue 8
2013 OctVol. 18 Supplement 4
APSR Congress Abstracts
2013 NovVol. 18 Supplement 3
Airway Inflammation
2013 OctVol. 18 Issue 7
2013 AugVol. 18 Issue 6
2013 JulVol. 18 Issue 5
2013 MayVol. 18 Issue 4
2013 AprVol. 18 Issue 3
2013 AprVol. 18 Supplement 2
ANZSRS and TSANZ abstracts
2013 AprVol. 18 Supplement 1
Airway Vista abstracts
2013 FebVol. 18 Issue 2
2013 JanVol. 18 Issue 1
2012 DecVol. 17 Supplement 2
APSR Congress Abstracts
2012 NovVol. 17 Issue 8
2012 OctVol. 17 Issue 7
2012 AugVol. 17 Issue 6
2012 JulVol. 17 Issue 5
2012 MayVol. 17 Issue 4
2012 AprVol. 17 Issue 3
2012 AprVol. 17 Supplement 1
ANZSRS and TSANZ abstracts
2012 FebVol. 17 Issue 2
2012 JanVol. 17 Issue 1
2011 NovVol. 16 Issue 8
2011 NovVol. 16 Supplement 2
APSR Congress Abstracts
2011 OctVol. 16 Issue 7
2011 AugVol. 16 Issue 6
2011 JulVol. 16 Issue 5
2011 MayVol. 16 Issue 4
2011 AprVol. 16 Issue 3
2011 AprVol. 16 Supplement 1
ANZSRS and TSANZ abstracts
2011 FebVol. 16 Issue 2
2011 JanVol. 16 Issue 1
2010 NovVol. 15 Supplement 2
APSR Congress Abstracts
2010 NovVol. 15 Issue 8
2010 OctVol. 15 Issue 7
2010 AugVol. 15 Issue 6
2010 JulVol. 15 Issue 5
2010 MayVol. 15 Issue 4
2010 AprVol. 15 Issue 3
2010 MarVol. 15 Supplement 1
ANZSRS and TSANZ abstracts
2010 FebVol. 15 Issue 2
2010 JanVol. 15 Issue 1
2009 NovVol. 14 Issue 8
2009 NovVol. 14 Supplement 3
APSR Congress Abstracts
2009 OctVol. 14 Supplement 2
Guidelines: Hospital-Acquired Pneumonia
2009 SepVol. 14 Issue 7
2009 Vol. 14 Issue 6
2009 JulVol. 14 Issue 5
2009 MayVol. 14 Issue 4
2009 AprVol. 14 Issue 3
2009 AprVol. 14 Supplement 1
ANZSRS and TSANZ abstracts
2009 MarVol. 14 Issue 2
2009 JanVol. 14 Issue 1
2008 NovVol. 13 Issue 7
2008 NovVol. 13 Supplement 5
APSR Congress Abstracts
2008 NovVol. 13 Supplement 4
Lung Disease
2008 SepVol. 13 Issue 6
2008 SepVol. 13 Supplement 3
ESAP: TB
2008 JulVol. 13 Issue 5
2008 JunVol. 13 Issue 4
2008 MayVol. 13 Issue 3
2008 AprVol. 13 Supplement 2
ANZSRS and TSANZ Abstracts
2008 MarVol. 13 Supplement 1
ESAP Abstracts
2008 MarVol. 13 Issue 2
2008 JanVol. 13 Issue 1
2007 NovVol. 12 Supplement 4
APSR Congress Abstracts
2007 NovVol. 12 Supplement 3
Asthma
2007 NovVol. 12 Issue 6
2007 SepVol. 12 Issue 5
2007 JulVol. 12 Issue 4
2007 MayVol. 12 Supplement 2
ESAP Abstracts
2007 MayVol. 12 Issue 3
2007 MarVol. 12 Supplement 1
ANZSRS and TSANZ Abstracts
2007 MarVol. 12 Issue 2
2007 JanVol. 12 Issue 1
2006 NovVol. 11 Supplement 5
APSR Congress Abstracts
2006 NovVol. 11 Issue 6
2006 SepVol. 11 Supplement 4
Guidelines: Cough
2006 SepVol. 11 Supplement 3
Guidelines: Respiratory Infections
2006 SepVol. 11 Issue 5
2006 JulVol. 11 Issue 4
2006 MayVol. 11 Issue 3
2006 MarVol. 11 Supplement 2
ANZSRS and TSANZ abstracts
2006 MarVol. 11 Issue 2
2006 JanVol. 11 Supplement 1
Surfactant Molecular Pathophysiology
2006 JanVol. 11 Issue 1
2005 NovVol. 10 Supplement 3
APSR Congress Abstracts
2005 NovVol. 10 Supplement 2
Respiratory function tests
2005 NovVol. 10 Issue 5
2005 SepVol. 10 Issue 4
2005 JunVol. 10 Issue 3
2005 MarVol. 10 Supplement 1
ANZSRS and TSANZ abstracts
2005 MarVol. 10 Issue 2
2005 JanVol. 10 Issue 1
2004 DecVol. 9 Supplement 3
APSR Congress Abstracts
2004 NovVol. 9 Issue 4
2004 AugVol. 9 Issue 3
2004 JunVol. 9 Issue 2
2004 MarVol. 9 Supplement 2
APSR Congress Abstracts
2004 MarVol. 9 Supplement 1
Guidelines: Hospital-Acquired Pneumonia
2004 MarVol. 9 Issue 1
2003 DecVol. 8 Issue 4
2003 NovVol. 8 Supplement 1
SARS
2003 SepVol. 8 Issue 3
2003 JunVol. 8 Issue 2
2003 AprVol. 8 Supplement 2
APSR Congress Abstracts
2003 MarVol. 8 Issue 1
2002 DecVol. 7 Issue 4
2002 SepVol. 7 Issue 3
2002 JunVol. 7 Issue 2
2002 MarVol. 7 Supplement 1
APSR Congress Abstracts
2002 MarVol. 7 Issue 1
2001 DecVol. 6 Issue 4
2001 SepVol. 6 Issue 3
2001 JunVol. 6 Supplement 2
Chronic Obstructive Lung Diseases
2001 JunVol. 6 Issue 2
2001 MarVol. 6 Issue 1
2000 DecVol. 5 Issue 4
2000 SepVol. 5 Issue 3
2000 JunVol. 5 Issue 2
2000 JunVol. 05 Supplement 2
TSANZ abstracts
2000 AprVol. 05 Supplement 1
TSANZ abstracts
2000 MarVol. 5 Issue 1
1999 DecVol. 4 Issue 4
1999 SepVol. 4 Issue 3
1999 JunVol. 4 Issue 2
1999 AprVol. 04 Supplement 1
TSANZ abstracts
1999 JanVol. 4 Issue 1
1998 DecVol. 3 Issue 4
1998 SepVol. 3 Issue 3
1998 JunVol. 3 Issue 2
1998 MarVol. 3 Issue 1
1997 DecVol. 2 Issue 4
1997 SepVol. 2 Issue 3
1997 JunVol. 2 Issue 2
1997 MarVol. 2 Issue 1
1996 DecVol. 1 Issue 4
1996 SepVol. 1 Issue 3
1996 JunVol. 1 Issue 2
1996 MarVol. 1 Issue 1